Drug Shortage Report for BRIVLERA
Report ID | 115679 |
Drug Identification Number | 02452936 |
Brand name | BRIVLERA |
Common or Proper name | BRIVARACETAM |
Company Name | UCB CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | BRIVARACETAM |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 60 TABS/BOTTLE |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2020-05-25 |
Actual start date | |
Estimated end date | 2020-06-08 |
Actual end date | 2020-06-02 |
Shortage status | Resolved |
Updated date | 2020-06-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2201 BRISTOL CIRCLE OAKVILLE, ONTARIO CANADA L6H 0J8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-06-03 | French | Compare |
v4 | 2020-06-03 | English | Compare |
v3 | 2020-05-26 | English | Compare |
v2 | 2020-05-25 | French | Compare |
v1 | 2020-05-25 | English | Compare |
Showing 1 to 5 of 5